|
Post by kc on May 1, 2018 13:30:58 GMT -5
Henry can make purchases at market and buy it on the cheap if he wanted too.
|
|
|
Post by kc on May 1, 2018 13:00:48 GMT -5
even smaller lots..... 13:51:35 thru 13:55:59 shares of 10,5, 7, 1, 14, 3, 2, Very weird trading ranges.
any explanations
|
|
|
Post by kc on May 1, 2018 12:54:36 GMT -5
Paint drying today. look at the odd lots? IS THERE A MESSAGE?
8, 9, 10 20 shares trading over extended time frames.
|
|
|
Post by kc on May 1, 2018 10:00:53 GMT -5
Someone on these boards that listened to the call said that it was a bit garbled, but the fine should have been signed. SA never got the memo I guess Which makes sense. While fine may be grammatically correct, who talks like that? I think the term sheet was embroidered on silk, surely Perhaps they're drafting the final agreement in the same medium, thus causing the delay... or Amphastar is taking the full time to review (wild rumor mongering on my part) It was signed in invisible ink........
|
|
|
Post by kc on May 1, 2018 9:54:25 GMT -5
Researching Healthline a bit more, I found this article from 2013. “To elaborate, we also had a roundtable discussion with various Lilly officials, who told us about their plans for developing new basal and fast-acting insulin. The details are a post in itself, but one fascinating note was how Drs. David Moller and David Kendall both insist that smart, glucose-responsive insulin is "aspirational and over-hyped on timeline," and that faster-acting insulin is what's next in the coming years.” www.healthline.com/diabetesmine/lilly-diabetes-summit-sequel-a-peek-at-insulin-giants-workings#1 Anyone who thinks he was fired has E.coli for brains. I thought this passage from the article was very interesting. Five years later, not much has changed. “In talking about these products, D-blogger Bennet Dunlap urged Lilly to work with doctors more on communicating that insulin can be a way to succeed in D-management, rather than using a "treat to fail" approach in resisting insulin treatment. Lilly's Patty Martin acknowledged they haven't done that well, and they plan to improve.” Its Just INSULIN stupid.... Big Pharma likes to play games with adding stuff to the most basic treatment for diabetes. Kendall understands how Afrezza works. creating hybrid designer drugs they can charge more $$$$ for than basic insulin.
|
|
|
Post by kc on May 1, 2018 9:34:57 GMT -5
I was hoping to quote from a recent article concerning Dr. Kendall below: www.healthline.com/diabetesmine/david-kendall-from-lilly-to-Afrezza-inhaled-insulin#7However, when I use the web address, the article is no longer there. Does anyone have a way to contact Mike Hoskins to let him know the article isn’t there on the website at the moment or being redirected to the wrong article? Anyway, in the article Dr. Kendall was quoted as saying that he started work the next day after leaving Lilli. Dr. Kendall said that MannKind got a free week of work from him. I loved that quote because it says to me that Dr. Kendall was so excited about starting his work at MannKind, he didn’t bother to take a down week after his employment ended at Lilli. That is the kind of dedication we want to see from every employee at MannKind but especially refreshing to see it from someone so important to the company. I guess that Lily wanted the article off the net. Don't draw any attention to it.
|
|
|
Post by kc on May 1, 2018 9:32:52 GMT -5
m.huffpost.com/us/entry/us_58af1626e4b0e5fdf6196f04/ampAlthough my home state of California, like several other states, will not recognize non-compete agreements, I am always surprised at how many companies still think that forcing employees to sign these them will prevent them from later working for the company’s competitors The confidentiality part of Non-Competes are enforceable and still valid.
|
|
|
Post by kc on Apr 29, 2018 12:27:01 GMT -5
I meant prior to a video presentation. For instance prior to Steven Colbert on youtube. Prior to Seth Meyers. Nobody is watching Steven Colbert or Seth Meyers. They have turned off most of their audience with their political reteroric. Same things goes for Jimmy Kimmel. They should stock to humor or their light night gig is over.
|
|
|
Post by kc on Apr 26, 2018 22:25:17 GMT -5
My shares were always 100% loaned until just the last few weeks. Something has changed. Yes, 14M shares were recently sold by MNKD but that was not the first dilution in the last few years. When the 10M shares were sold last year at $6, my loaned shares were not returned. They make good profit on the spread between the interest they pay vs the interest they charge, so I don’t know what you mean when you say “Fidelity is very conservative”. I have never seen shares available to short MNKD when trading on the Fidelity platform in over three years. MNKD was not the only stock either. I was never able to locate them either via customer service. IB and Lightspeed have made shares available over the last year. it is just an observation when I was trading with them versus other brokers. In my opinion only the institutions can short MNKD at Fidelity due to policys from their risk department. The shares are available at Fidelity to short if you have the proper type of account. Generally people who are shorting a stock have tremendous asset’s pledged as they would have to pay the brokerage house back if they’re short did not work out. The short is not much different then a Vegas gambler. The house rarely loses in Vegas. The same can be said about brokerage houses.
|
|
|
Post by kc on Apr 26, 2018 11:30:02 GMT -5
Fidelity only paying 10.875% today to loan. About 75% of my shares are loaned out. Just about every day shares are being lent out and or returned to one or both of my accounts. I’m surprised that Fidelity would still have MNKD as “hard to borrow” when shares are available and interest keeps dropping daily. I don't believe that Fidelity wants its retail clients to short MNKD, so they keep it HTB. For the most part Fidelity is very conservative I really don’t believe that retail customers are shorting the stock. Fidelity deals with all types of clients. Not just retail.
|
|
|
Post by kc on Apr 26, 2018 9:06:01 GMT -5
Loan rate decreased to 9% at Schwab. I liked it better when Fidelity was at 113.75% in February 2017
But today they are at 25% on the HTB list.
|
|
|
Post by kc on Apr 25, 2018 19:21:31 GMT -5
[ There is a whole lot less risk in my game plan then yours. Expect about tAt least two dilutions during he warrant redemption if the stock price does not clear three and some change C'mon, Dennis, the only risk in your game plan is if the stock goes up! I violated my 12 step program and purchased more shares last week. My MannKind Addiction it’s worst than being on Crack. $1.75 per share.
|
|
|
Post by kc on Apr 25, 2018 10:22:21 GMT -5
|
|
|
Post by kc on Apr 24, 2018 18:16:21 GMT -5
So Will there be a press release tomorrow? Maybe this evening? Maybe not yet.... keep the surprise element for ADA. What is behind the curtain? Only The wizard knows.
|
|
|
Post by kc on Apr 24, 2018 18:04:10 GMT -5
One question, if this is a week old and is such an important point for Afrezza, why didn't Mannkind PR it a week ago? Nevermind it seems to be electronically signed today This is a representation of an electronic record that was signed electronically and this page is the manifestation of the electronic signature. -------------------------------------------------------------------------------------------- /s/ ------------------------------------------------------------ JENNIFER R PIPPINS 04/24/2018 There are always reasons for release timing. Tick tick tick Kaboom!
|
|